亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Validation of the Partin Nomogram for Prostate Cancer in a National Sample

列线图 医学 前列腺切除术 前列腺癌 泌尿科 淋巴 阶段(地层学) 前列腺 前列腺特异性抗原 淋巴结 根治性耻骨后前列腺切除术 癌症 妇科 肿瘤科 内科学 病理 古生物学 生物
作者
James B. Yu,Danil V. Makarov,Richa Sharma,Richard E. Peschel,Alan W. Partin,Cary P. Gross
出处
期刊:The Journal of Urology [Ovid Technologies (Wolters Kluwer)]
卷期号:183 (1): 105-111 被引量:55
标识
DOI:10.1016/j.juro.2009.08.143
摘要

No AccessJournal of UrologyAdult Urology1 Jan 2010Validation of the Partin Nomogram for Prostate Cancer in a National Sample James B. Yu, Danil V. Makarov, Richa Sharma, Richard E. Peschel, Alan W. Partin, and Cary P. Gross James B. YuJames B. Yu Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut More articles by this author , Danil V. MakarovDanil V. Makarov Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut More articles by this author , Richa SharmaRicha Sharma School of Epidemiology and Public Health, Yale School of Medicine, New Haven, Connecticut More articles by this author , Richard E. PeschelRichard E. Peschel Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut More articles by this author , Alan W. PartinAlan W. Partin The Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland More articles by this author , and Cary P. GrossCary P. Gross Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2009.08.143AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The Partin tables are a nomogram that is widely used to discriminate prostate cancer pathological stages, given common preoperative clinical characteristics. The nomogram is based on patients undergoing radical prostatectomy at The Johns Hopkins Medical Institutions. We validated the Partin tables in a large, population based sample. Materials and Methods: The National Cancer Institute Surveillance, Epidemiology and End Results database was used to identify patients treated from 2004 to 2005 who underwent radical prostatectomy. The 2007 Partin tables were used to estimate the prevalence of positive lymph nodes, seminal vesicle invasion, extraprostatic extension and organ confined disease in men with prostate cancer in the database using clinical stage, preoperative prostate specific antigen and Gleason score. The discriminative ability of the tables was explored by constructing ROC curves. Results: We identified 11,185 men who underwent radical prostatectomy for prostate cancer in 2004 to 2005. The Partin tables discriminated well between patient groups at risk for positive lymph nodes and seminal vesicle invasion (AUC 0.77 and 0.74, respectively). The discrimination of extraprostatic extension and organ confined disease was more limited (AUC 0.62 and 0.68, respectively). The AUC for positive lymph nodes was 0.78 in white men, 0.73 in black men and 0.83 in Asian/Pacific Islander men (p = 0.17). The AUC for positive lymph nodes in men 61 years old or younger was 0.80 vs 0.74 in men older than 61 years (p = 0.03). Conclusions: The Partin tables showed excellent discrimination for seminal vesicle invasion and positive lymph nodes. Discrimination of extraprostatic extension and organ confined disease was more limited. The Partin tables performed best in young men. References 1 : Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA1994; 271: 368. Google Scholar 2 : The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol1993; 150: 110. Abstract, Google Scholar 3 : Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA1997; 277: 1445. Google Scholar 4 : Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology2001; 58: 843. Google Scholar 5 : Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin Tables) based on cases from 2000 to 2005. Urology2007; 69: 1095. Google Scholar 6 : Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins experience. Urol Clin North Am2001; 28: 555. Google Scholar 7 : The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. Urology2008; 71: 151. Google Scholar 8 : How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population?: Results of the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol2002; 167: 1653. Link, Google Scholar 9 : Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol2000; 164: 1591. Link, Google Scholar 10 : Comparison of accuracy between Partin tables of 1997 and 2001 to predict final pathologic stage in clinically localized prostate cancer. J Urol2004; 171: 177. Link, Google Scholar 11 : External validation of the updated Partin tables in a cohort of North American men. J Urol2008; 180: 898. Link, Google Scholar 12 : Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. Eur J Surg Oncol2009; 35: 123. Google Scholar 13 : External validation of the updated Partin tables in a cohort of French and Italian men. Int J Radiat Oncol Biol Phys2009; 73: 347. Google Scholar 14 Surveillance, Epidemiology, and End Results Program Limited-Use Data (1973–2005), National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission (www.seer.cancer.gov). Google Scholar 15 National Cancer Institute: Collaborative Staging Manual and Coding Instructions. http://seer.cancer.gov/tools/collabstaging/index.html. Accessed August 9, 2008. Google Scholar 16 : Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/ml and lower. Cancer2008; 113: 2695. Google Scholar 17 : Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics1988; 44: 837. Google Scholar 18 : Verification of forecasts expressed in terms of probabilities. Mon Wea Rev1950; 78: 1. Google Scholar 19 : Tumor thickness predicts a five-year survival equally as well as more complex prognostic model. Evidence Based Oncol2000; 1: 10. Google Scholar 20 : Investigating black-white differences in prostate cancer prognosis: a systematic review and meta-analysis. Int J Cancer2008; 123: 430. Google Scholar 21 Unequal Treatment, Confronting Racial and Ethnic Disparities in Healthcare: Institute of Medicine. Washington, D.C: National Academies Press2001. Google Scholar 22 : Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst2002; 94: 981. Google Scholar 23 : Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma. Cancer2003; 97: 56. Google Scholar 24 : Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy. Int J Radiat Oncol Biol Phys1995; 32: 479. Google Scholar 25 : Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol2005; 174: 2181. Link, Google Scholar 26 : Percent tumor involvement and risk of biochemical progression after radical prostatectomy. J Urol2008; 180: 571. Link, Google Scholar 27 : Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol1996; 14: 1770. Google Scholar 28 : PSA velocity is associated with Gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness. Urology1689; 109. Google Scholar 29 : Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int2006; 98: 788. Google Scholar 30 : Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer. Urology2008; 71: 141. Google Scholar © 2010 by American Urological AssociationFiguresReferencesRelatedDetailsCited byÖtleş E, Denton B, Qu B, Murali A, Merdan S, Auffenberg G, Hiller S, Lane B, George A and Singh K (2021) Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National CohortsJournal of Urology, VOL. 207, NO. 2, (358-366), Online publication date: 1-Feb-2022. Volume 183Issue 1January 2010Page: 105-111 Advertisement Copyright & Permissions© 2010 by American Urological AssociationKeywordsneoplasm stagingnomogramsprostateSEER programprostatic neoplasmsMetricsAuthor Information James B. Yu Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut More articles by this author Danil V. Makarov Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut More articles by this author Richa Sharma School of Epidemiology and Public Health, Yale School of Medicine, New Haven, Connecticut More articles by this author Richard E. Peschel Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut More articles by this author Alan W. Partin The Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland More articles by this author Cary P. Gross Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut More articles by this author Expand All Advertisement PDF downloadLoading ...
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花应助科研通管家采纳,获得10
13秒前
jyy应助科研通管家采纳,获得10
13秒前
TXZ06完成签到,获得积分10
17秒前
31秒前
jason发布了新的文献求助10
36秒前
yan完成签到,获得积分10
42秒前
1分钟前
wanci应助yan采纳,获得10
1分钟前
1分钟前
yan发布了新的文献求助10
1分钟前
科研通AI2S应助阿欢采纳,获得10
1分钟前
1分钟前
幸福顺意完成签到 ,获得积分10
1分钟前
苦杏仁发布了新的文献求助10
2分钟前
3分钟前
Phil完成签到 ,获得积分10
3分钟前
水豚完成签到,获得积分10
3分钟前
3分钟前
cy0824完成签到 ,获得积分10
4分钟前
jyy应助科研通管家采纳,获得10
4分钟前
4分钟前
空2完成签到 ,获得积分10
5分钟前
6分钟前
6分钟前
YWJ关注了科研通微信公众号
6分钟前
6分钟前
世隐完成签到,获得积分10
6分钟前
6分钟前
YWJ发布了新的文献求助10
7分钟前
领导范儿应助dr0422采纳,获得10
7分钟前
7分钟前
wanci应助thousandlong采纳,获得10
7分钟前
jerry发布了新的文献求助10
7分钟前
7分钟前
thousandlong发布了新的文献求助10
7分钟前
你好完成签到 ,获得积分10
7分钟前
8分钟前
完美世界应助jerry采纳,获得10
8分钟前
jerry完成签到,获得积分10
8分钟前
思源应助Q哈哈哈采纳,获得10
9分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Semiconductor Process Reliability in Practice 720
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
The Heath Anthology of American Literature: Early Nineteenth Century 1800 - 1865 Vol. B 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3229680
求助须知:如何正确求助?哪些是违规求助? 2877243
关于积分的说明 8198570
捐赠科研通 2544698
什么是DOI,文献DOI怎么找? 1374568
科研通“疑难数据库(出版商)”最低求助积分说明 646996
邀请新用户注册赠送积分活动 621808